Dasatinib F317L BCR-ABL Mutasyonu Olan Kronik Miyeloid Lösemi Hastalarında Etkili Olabilir

Journal Title: Turkish Journal of Hematology - Year 2013, Vol 30, Issue 2

Abstract

Authors and Affiliations

Ahmet Eşkazan, Teoman Soysal

Keywords

Related Articles

TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms

We aimed to determine the genotype distribution, allele frequency, and prognostic impact of IDH1/2, TET2, and ASXL1 single nucleotide polymorphisms (SNPs) in myeloproliferative neoplasms (MPNs). TET2 (rs763480), ASXL1 (r...

Bortezomib-Associated Severe Orthostatic Hypotension and Hyponatremia

To the Editor, The most frequent side effects of bortezomib are fatigue, hematologic toxicity with cytopenias, and peripheral neuropathy, whereas postural hypotension and hyponatremia are less common late side effects [...

Aplastic anemia presenting as hemophagocytic lymphohistiocytosis

Two unusual cases of hemophagocytic lymphohistiocytosis (HLH) complicating aplastic anemia (AA) are described. Each patient had a history of preexisting acute hepatitis of unknown cause at the time of HLH diagnosis and i...

Download PDF file
  • EP ID EP153079
  • DOI 10.4274/Tjh.2012.0013
  • Views 60
  • Downloads 0

How To Cite

Ahmet Eşkazan, Teoman Soysal (2013). Dasatinib F317L BCR-ABL Mutasyonu Olan Kronik Miyeloid Lösemi Hastalarında Etkili Olabilir. Turkish Journal of Hematology, 30(2), 211-213. https://europub.co.uk/articles/-A-153079